University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, ...

Tiffany Young, an Aurora Health Care nurse, recently changed her career to specialize in helping cancer patients after her ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

She shares the story of her inspiring journey and the treatment that may have helped to save her life.

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic ...